AzTrials
AzTrials

Respiratory FailureNCT03178565

The Effects of Mechanical Insufflation-exsufflation on Airway Mucus Clearance in the ICU

A study testing Mechanical insufflation-exsufflation and Standard Respiratory Physiotherapy in people with Respiratory Failure, run by Hospital Moinhos de Vento at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The present study aims to evaluate the effect of mechanical insufflation-exsufflation on airway mucus clearance among mechanically ventilated ICU patients. A parallel group randomized clinical trial will be conducted in a single mixed medical-surgical ICU of a tertiary hospital in Southern Brazil. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Respiratory Failure
What is being tested?
Mechanical insufflation-exsufflation and Standard Respiratory Physiotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
170 participants
Where
1 siteBrazil
Study dates
Dec 2016to Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years;
  • Admission to the ICU
  • Length of mechanical ventilation > 24 hours
  • Stable ventilatory and hemodynamic status defined by positive end- expiratory pressure ≤ 8 cm H2O, inspiratory oxygen fraction ≤ 40%, ratio of arterial oxygen partial pressure to fractional inspired oxygen ≥ 150, respiratory rate ≤ 35 breaths per minute, heart rate ≤ 130 beats per minute and systolic blood pressure between 90 and 160 mmHg.

Who cannot join

  • Patients with primary neuromuscular disease.
  • Patients in exclusive paliative care.
  • Patients with contraindications to the use of mechanical insufflation- Exsufflation device.

Trial locations and contacts

1 site in 1 country.

Brazil1 site, 1 recruiting
  • Hospital Moinhos de Vento

    Porto Alegre, Rio Grande do Sul, 90035001

    Cassiano Teixeira, MD, 555133143387, cassiano.rush@gmail.com

    Marcio Camillis

    Recruiting

Other trials in Brazil

About this study

Official title: The Effects of Mechanical Insufflation-exsufflation for Airway Mucus Clearance Among Mechanically Ventilated ICU Patients: a Randomized Trial

The present study aims to evaluate the effect of mechanical insufflation-exsufflation on airway mucus clearance among mechanically ventilated ICU patients. A parallel group randomized clinical trial will be conducted in a single mixed medical-surgical ICU of a tertiary hospital in Southern Brazil. Adult ICU patients with a length of mechanical ventilation >24 hours will be evaluated for eligibility. Patients will be randomized in a 1:1 ratio to receive respiratory physiotherapy using a mechanical insufflation-exsufflation device (intervention group) or standard respiratory physiotherapy without the use of the mechanical insufflation-exsufflation device (control group). The primary outcome is the amount of aspirated respiratory mucus (weight in grams) 5 minutes after the finish of respiratory physiotherapy.

Being tested
Mechanical insufflation-exsufflation, Standard Respiratory Physiotherapy
Keywords
Respiratory Failure, Mechanical Ventilation, Mechanical insufflation-exsufflation, Airway mucus clearance
Medical subject headings
Respiratory Insufficiency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mechanical insufflation-exsufflationOther

    Also called CoughAssist

    The mechanical insufflation-exsufflation device will be connected in the orotracheal tube. Four series of insufflation-exsufflation will be conducted. Each serie will be composed by 10 cycles of alternated insufflation (40 cmH2O) and exsufflation (- 40 cmH2O).

  • Standard Respiratory PhysiotherapyOther

    Standard chest physiotherapy will be conducted through bilateral thoracic maneuvers (percussion and vibration) followed by manual hyperinflation using a manual resuscitator bag.

Study groups in NCT03178565
Study groupRoleWhat they receive
Intervention GroupExperimentalRespiratory physiotherapy using a mechanical insufflation-exsufflation device (CoughAssist)
Receives: Other: Mechanical insufflation-exsufflation
Control GroupActive comparatorRespiratory physiotherapy according standard of care - without the use of a mechanical insufflation-exsufflation device.
Receives: Other: Standard Respiratory Physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Amount of aspirated secretion

    Single measure of weight in grams of the aspirated secretion 5 minutes after the study intervention (mechanical insufflation-exsufflation or standard respiratory physiotherapy).

    Measured: This outcome will be verified 5 minutes after the completion of the study intervention on the day of subject enrollment.

Secondary outcomes (2)
  1. Static lung compliance

    Single measure of the static lung compliance in mL/cm H2O

    Measured: This outcome will be verified 5 minutes after the completion of the study intervention on the day of subject enrollment.

  2. Airway resistance

    Single measure of the airway resistance in cm H2O/L/s

    Measured: This outcome will be verified 5 minutes after the completion of the study intervention on the day of subject enrollment.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2017
  2. Study startDec 2016
  3. Primary completionNov 2017 (estimated)
  4. Study completionNov 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Mechanically ventilated patients will be randomized to receive respiratory physiotherapy using a mechanical insufflation-exsufflation device (intervention group) or to receive standard respiratory physiotherapy without the use of a mechanical insufflation-exsufflation device (control group).
Masking
None (open label)
Enrolment
170 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03178565
Sponsor's protocol ID
CoughAssist trial
Status last verified
Jun 2017
First submitted
21 Apr 2017
Last updated
7 Jun 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Ferreira de Camillis ML, Savi A, Goulart Rosa R, Figueiredo M, Wickert R, Borges LGA, Galant L, Teixeira C. Effects of Mechanical Insufflation-Exsufflation on Airway Mucus Clearance Among Mechanically Ventilated ICU Subjects. Respir Care. 2018 Dec;63(12):1471-1477. doi: 10.4187/respcare.06253. Epub 2018 Jul 17.

    PubMed 30018175

Questions about this trial

What is this clinical trial studying?

A study testing Mechanical insufflation-exsufflation and Standard Respiratory Physiotherapy in people with Respiratory Failure, run by Hospital Moinhos de Vento at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Marcio Camillis (55-51-996569173, marciocamillis@yahoo.com.br), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Amount of aspirated secretion (time frame: This outcome will be verified 5 minutes after the completion of the study intervention on the day of subject enrollment.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03178565, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in